1. Home
  2. MLAB vs GUG Comparison

MLAB vs GUG Comparison

Compare MLAB & GUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$96.27

Market Cap

489.8M

Sector

Industrials

ML Signal

HOLD

Logo Guggenheim Active Allocation Fund of Beneficial Interest

GUG

Guggenheim Active Allocation Fund of Beneficial Interest

HOLD

Current Price

$15.94

Market Cap

534.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
GUG
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Trusts Except Educational Religious and Charitable
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
489.8M
534.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
MLAB
GUG
Price
$96.27
$15.94
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$94.00
N/A
AVG Volume (30 Days)
70.4K
93.7K
Earning Date
05-04-2026
01-01-0001
Dividend Yield
0.67%
N/A
EPS Growth
99.24
N/A
EPS
1.95
N/A
Revenue
N/A
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$5.41
N/A
P/E Ratio
$48.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$13.90
52 Week High
$142.19
$16.50

Technical Indicators

Market Signals
Indicator
MLAB
GUG
Relative Strength Index (RSI) 64.97 50.95
Support Level $91.62 $15.46
Resistance Level $98.14 $16.17
Average True Range (ATR) 4.10 0.24
MACD 0.35 -0.03
Stochastic Oscillator 94.86 24.24

Price Performance

Historical Comparison
MLAB
GUG

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

Share on Social Networks: